Archive - Jul 17, 2018

Archive - Jul 17, 2018

Date

Using Epinephrine to Treat Cardiac Arrest: Minimal Benefit, Increased Risk of Brain Damage

WARWICK, UK--A clinical trial of the use of epinephrine (adrenaline) in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest. The research raises important questions about the future use of epinephrine in such cases and will necessitate debate among healthcare professionals, patients and the public.

Mission & Vision

The mission of the Sudden Cardiac Arrest (SCA) Foundation is to prevent death and disability from sudden cardiac arrest. The vision of the SCA Foundation is to increase awareness about sudden cardiac arrest and influence attitudinal and behavioral changes that will reduce mortality and morbidity from SCA.

SCA Newsletter

Sign Up with the SCA Foundation News in order to stay informed! (* required field)

Contact Us

The Sudden Cardiac Arrest Foundation would like to hear from you! If you have questions or comments — Contact Us!

724-625-0025

Sudden Cardiac Arrest Foundation
7500 Brooktree Road
Wexford, PA 15090

Copyright © 2019 Sudden Cardiac Arrest Foundation. All Rights Reserved.

Web Design & Development, & Web Hosting By FastWebEngine